Welcome to Coulter Partners Global (English)

21 January 2021

Top hires for VC & PE portfolio companies Q4-2020

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Drug delivery systems Germany
CEO Medical implants France
CEO Women's health Switzerland/US
Chief Commercial Officer CNS diseases US
Chief Financial Officer Clinical research services Europe
Chief Medical Officer Haemostasis therapeutics Netherlands
Chief Scientific Officer Vaccines Switzerland
Head of Growth/Chief Marketing Officer Digital health Germany
VP Research Stem cell therapy UK
VP Sales & Marketing US Genome editing technology Ireland
VP Commercial Europe In vitro diagnostic products Israel
Head of Regulatory Affairs US Rare diseases Switzerland
Head of Business Development US CDMO France
GM Tissues and Biologics Medical devices US
Head of M&A DACH Animal health Nordics
Director Human Resources Nanoparticles medicine Nordics
Associate Life science VC Netherlands
Board Director Regenerative therapeutic biologics US
Board Director Vaccines DACH

Newly opened projects include:

Function Focus area Location
CEO Dental implants Benelux
CEO Microbiome-based therapeutics US
Chief Medical Officer Vaccines Nordics
Chief Business Officer Oncology Switzerland
VP R&D Neurodegenerative diseases US
Group VP Technical Development CDMO Eastern Europe
Head of Business Development A.I. for drug discovery UK
VP Quality & Regulatory Affairs Medical devices UK
Senior US Venture Partner Life science VC UK
Partner Life science investor Belgium


A new version of Coulter Partners is available.